Lalitha K. Shankar, John M. Hoffman, Steve Bacharach et Michael M. Graham, «Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials», Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, vol.47, no6, , p.1059–1066 (ISSN0161-5505, PMID16741317, lire en ligne, consulté le )
Lalitha K. Shankar, John M. Hoffman, Steve Bacharach et Michael M. Graham, «Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials», Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, vol.47, no6, , p.1059–1066 (ISSN0161-5505, PMID16741317, lire en ligne, consulté le )
pubmed.ncbi.nlm.nih.gov
Lalitha K. Shankar, John M. Hoffman, Steve Bacharach et Michael M. Graham, «Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials», Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, vol.47, no6, , p.1059–1066 (ISSN0161-5505, PMID16741317, lire en ligne, consulté le )